PREP Repeal Act
- Bill Number
- H.R. 4388
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-07-15: Referred to the House Committee on Energy and Commerce.
- Last Updated
- 2025-12-16T09:05:27Z
AI-Generated Summary
Purpose of the Legislation
The PREP Repeal Act (H.R. 4388) aims to eliminate legal protections that shield certain entities from lawsuits during public health emergencies, specifically by repealing provisions of the Public Health Service Act related to the Public Readiness and Emergency Preparedness (PREP) Act. It seeks to restore accountability and the ability of individuals to seek justice for harms caused by pandemic-related products, such as vaccines or treatments.
Key Provisions
- Short Title: The bill is titled the "PREP Repeal Act."
- Findings: Congress states that PREP Act liability shields have eroded public trust, violated principles of justice and due process (the legal right to fair treatment and remedies for harm), and allowed undue influence by pharmaceutical companies over regulations at the cost of personal rights.
- Repeals and Rescissions:
- Fully repeals Section 319F-3 (liability immunity for "covered countermeasures" like drugs, devices, or biological products used in emergencies) and Section 319F-4 (which established a fund for processing related claims) of the Public Health Service Act.
- Cancels any unspent money in the Covered Countermeasure Process Fund.
- References in Law: Any mentions of the repealed sections in other federal laws will be treated as referring to their pre-repeal status; also amends the Federal Food, Drug, and Cosmetic Act to remove a cross-reference to the repealed section.
- Preservation of Rights: Explicitly allows people to pursue lawsuits under federal or state law for injuries from drugs, devices, biological products, or covered countermeasures, without limiting existing legal options.
- Application: The repeals apply to ongoing legal cases (including those under appeal) as of the enactment date and to any new claims filed afterward.
- Severability: If any part of the Act is ruled invalid by a court, the rest remains in effect.
Significant Changes to Existing Law
- Removes broad legal immunity granted under the PREP Act (enacted in 2005 and expanded during events like the COVID-19 pandemic), which previously protected manufacturers, distributors, administrators, and program planners from most lawsuits related to emergency countermeasures, except in cases of "willful misconduct" (intentional wrongdoing).
- Ends the special compensation fund for claims, shifting responsibility back to standard civil litigation processes.
- This reverses a key tool used in public health crises to encourage rapid development and distribution of products by minimizing legal risks.
Potential Impacts
- On Citizens: Individuals harmed by emergency health products (e.g., vaccines or treatments) could more easily file lawsuits for compensation, potentially increasing access to remedies but also raising costs for healthcare and insurance.
- On Government Agencies: Agencies like the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC) may face challenges in future emergencies, as the lack of immunity could slow product deployment; the fund rescission reduces available resources for claim processing.
- On International Relations: Minimal direct impact, though it could affect U.S. collaborations with global health organizations or foreign manufacturers by altering liability expectations in joint emergency responses.
- Broader Effects: May lead to more cautious innovation in pharmaceuticals during crises, potentially delaying availability of countermeasures, while enhancing public accountability.
Main Stakeholders Affected
- Individuals and Citizens: Those injured by covered products, who gain stronger legal recourse.
- Pharmaceutical Manufacturers and Distributors: Lose immunity protections, facing higher litigation risks and potential financial liabilities.
- Healthcare Providers and Administrators: Could be subject to lawsuits for administering products, increasing their legal exposure.
- Government Entities: HHS, CDC, and state health departments, which relied on PREP provisions for emergency management.
- Legal System: Courts and attorneys handling injury claims, likely seeing an increase in related cases.
Notable Legal, Constitutional, or Political Implications
- Legal: Shifts from a no-fault compensation system to traditional tort liability (civil lawsuits for damages), potentially overwhelming courts with claims but aligning with standard product liability laws.
- Constitutional: Reinforces due process rights under the Fifth and Fourteenth Amendments by preserving access to civil remedies, addressing concerns that immunity provisions limited fair legal recourse.
- Political: Introduced by Representatives Thomas Massie and Paul Gosar, it reflects debates over emergency powers and corporate accountability, particularly in response to implementations during the COVID-19 pandemic; if passed, it could influence future public health legislation by prioritizing individual rights over expedited protections.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (3)
Rep. Gosar, Paul A. [R-AZ-9], Rep. Davidson, Warren [R-OH-8], Rep. Grothman, Glenn [R-WI-6]
Recent Actions
- 2025-07-15: Referred to the House Committee on Energy and Commerce.
- 2025-07-15: Introduced in House
- 2025-07-15: Introduced in House
Bill Versions
- PREP Repeal Act — issued 2025-07-15 — PDF (4 pages)